ENROFLON® 2.5%, 5%, 10%

1 ml contains 25, 50 or 100 mg of enrofloxacin


Pharmacological properties

Enrofloxacin possesses wide range of antimicrobial and antimycoplasmal activity. It suppresses the growth of gram-positive and gram-negative microorganisms, including E. coli, Haemophilus spp., Klebsiella spp., Pasteurella spp., Pseudomonas spp., Bordetella spp., Campylobacter spp., Erysipelothrix spp., Corynebacterium spp., Staphylococcus spp., Streptococcus spp., Actinobacillus spp., Clostridium spp., Bacteroides spp., Fusobacterium spp., and Mycoplasma spp.


• Treatment of bronchopneumonia, colibacillosis, salmonellosis and other diseases in calves, lambs and piglets, caused by fluoroquinolonesensitive microorganisms.

• Treatment of atrophic rhinitis, enzootic pneumonia and MMA syndrome in pigs.


ENROFLON® is administered once a day subcutaneously to calves and lambs and intramuscularly to piglets at a dose of 2.5-5.0 mg of enrofloxacin/kg bw for 3-5 days. For sows in the case of MMA syndrome ENROFLON® is administered intramuscularly at a dose of 2.5 mg of enrofloxacin/kg bw for 1-2 days. For calves and sows ENROFLON® to be administered in the quantities not more than 10 ml per site, for lambs - not more than 5 ml per site, for piglets - not more than 2.5 ml per site.

Come back